AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glafis M 1mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Ersa Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glafis M 1mg/500mg Tablet PR

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as discontinuation without medical advice can lead to elevated glucose levels, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle significantly impacts diabetes control. The most prevalent adverse effect of Diabex Duo is hypoglycemia (low blood sugar). Learn to recognize symptoms such as sweating, lightheadedness, headache, and tremors, and know how to treat them. Maintaining regular meals and carrying a readily available fast-acting glucose source, like sugary snacks or juice, is crucial. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart conditions before commencing treatment, as it may not be suitable. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Glafis M 1mg/500mg Tablet PR

No information provided. Please provide the text you wish to be rephrased.

Uses of Glafis M 1mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glafis M 1mg/500mg Tablet PR:

Follow your doctor's instructions or refer to the product label for dosage information. Glafis M 1mg/500mg Tablet PR should be administered with a meal.

Common Side effects of Glafis M 1mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glafis M 1mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Glafis M 1mg/500mg Tablet PR with food.

How Glafis M 1mg/500mg Tablet PR works:

Glafis M tablets (1mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Glafis M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glafis M 1mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glafis M 1mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glafis M 1mg/500mg Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glafis M 1mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glafis M 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, Glafis M 1mg/500mg Tablet PR is typically initiated at a reduced dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glafis M 1mg/500mg Tablet PR :

Should you forget a Glafis M 1mg/500mg Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glafis M 1mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glafis M 1mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glafis M 1mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glafis M 1mg/500mg Tablet PR and seek immediate medical attention.
Glafis M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glafis M 1mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glafis M 1mg/500mg Tablet PR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental Vitamin B12 intake, at least annually, is recommended by some researchers.
Glafis M 1mg/500mg Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glafis M 1mg/500mg tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glafis M 1mg/500mg Tablet...
65
MRP 75
13% off